NumFin

Wockhardt Limited

符号: WOCKPHARMA.BO

BSE

533.1

INR

今天的市场价格

  • -9.3464

    市盈率

  • 1.4697

    PEG比率

  • 81.77B

    MRK市值

  • 0.00%

    DIV收益率

Wockhardt Limited (WOCKPHARMA-BO) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 Wockhardt Limited (WOCKPHARMA.BO). 的默认数据。公司收入显示 35587.856 M 的平均值，即 0.054 % 增长率。整个期间的平均毛利润为 21587.101 M，即 0.058 %. 平均毛利率为 0.602 %. 公司去年的净收入增长率为 1.291 %，等于 0.257 % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 Wockhardt Limited 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 -0.068. 在流动资产领域，WOCKPHARMA.BO 的报告货币为22080. 这些资产中的很大一部分，即 900 是现金和短期投资。与去年的数据相比，该部分的变化率为-0.757%. 公司的长期投资虽然不是其重点，但以报告货币计算的170（如果有的话）为170。这表明与上一报告期相比，-5.556% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 4500. 这一数字表明，-0.006% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 33540. 这方面的年同比变化率为 -0.129%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为7970，存货估值为 6580，商誉估值为 9450（如有. 无形资产总额（如果有）按 12000 估值. 应付账款和短期债务分别为 8670 和 17340. 债务总额为21840，债务净额为 20940. 其他流动负债为 7610，加上总负债 40210. 最后，如果存在推荐股票，则其估值为 0.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008200720062005

balance-sheet.row.cash-and-short-term-investments

205090037002360
2650.7
4431.1
12886.7
21902.3
14726.6
15631.2
16942.2
10494.5
6894.1
4828.9
8324.2
12805.1
5720.7
11108.5
7139.3

balance-sheet.row.short-term-investments

12106008040
457.3
457.7
3914.3
12265.9
8096.8
4062.6
5942
2.7
7.9
2713
4854.4
6306
1918.9
1376.7
0

balance-sheet.row.net-receivables

15110797096809176.5
12515.4
12940.8
9707.6
10636.9
11317.3
7926.5
0
0
7692.7
6052.4
0
0
0
0
0

balance-sheet.row.inventory

12930658076907990
6950.6
8193.6
8557.1
11079.5
11021.6
10207.8
9928.9
10588.3
8885.6
7137.3
7654.5
8297.5
7687.4
4300
2746.5

balance-sheet.row.other-current-assets

5840309034002385.9
1979.6
1748.4
1781.6
1397
971.4
871.8
0
0
1342.7
1003.5
0
0
0
0
0

balance-sheet.row.total-current-assets

42450220802589024250
24298.3
28146.5
33796
45352.7
39518.5
34637.3
33559.2
33269.3
24815.1
19022.1
21718.8
29636.9
20108.8
20024.1
13605.2

balance-sheet.row.property-plant-equipment-net

47840243602860029144.4
33153.5
30242.2
29870.5
29133.4
28454.3
25832.6
20470.2
16413.2
16026.1
14683.9
16614.3
16341.9
13713.2
10267.1
13692.3

balance-sheet.row.goodwill

18780945089109040
8751.9
8205.6
8405.8
7365.1
7930
7145.2
8502.6
7263.5
13331.6
14906.6
14474.6
18271.8
15805.3
5619.3
0

balance-sheet.row.intangible-assets

2455012000105309040
8962.8
6586.3
4929
3666.5
2063.2
931.4
1048.8
1128.7
5378.6
4838.7
1281.2
1683
1194.2
1181.3
0

balance-sheet.row.goodwill-and-intangible-assets

43330214501944018080
17714.7
14791.9
13334.8
11031.6
9993.2
8076.6
9551.4
8392.2
18710.2
19745.3
15755.7
19954.9
16999.5
6800.6
0

balance-sheet.row.long-term-investments

79017018013.9
22.1
18.5
365.4
328.5
326.3
-4036.4
-5915.8
23.6
899.6
139.8
-3906.1
-5374.1
-1209.5
-1373.6
0

balance-sheet.row.tax-assets

11720608057303980
4294.2
2732.7
1835.6
1728.4
1450.7
1673.6
8463.6
242
2087.4
748.5
476.4
415.1
0
10475.7
0

balance-sheet.row.other-non-current-assets

4900269025902271.7
2306.3
2511.3
2418.1
2642.2
1465.6
11061.6
8555.2
3772.6
2087.4
2713
6489.7
7744.8
1918.9
1376.7
-5808.4

balance-sheet.row.total-non-current-assets

108580547505654053490
57490.8
50296.6
47824.4
44864.1
41690.1
37077.2
32661
26957.3
37723.3
38030.5
35430
39082.7
31422.1
17070.9
7883.9

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

151030768308243077740
81789.1
78443.1
81620.4
90216.8
81208.6
71714.5
66220.2
60226.6
62538.4
57052.6
57148.8
68719.6
51530.9
37095
21489.1

balance-sheet.row.account-payables

16670867092106960
8952.7
8402.4
6017.8
5338.1
6376.9
5525.6
5577.9
6341.5
5408
4365.8
4354.4
5234.5
4506.1
2798.6
0

balance-sheet.row.short-term-debt

28410173401576018920
20348.4
14831.3
15747.1
9685.4
7560
8252.3
8037.8
5953.2
7861.1
3900.6
42
66.1
99.5
60
0

balance-sheet.row.tax-payables

360220180690
9.7
61.9
601.3
529.9
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

16170450062207820
15474.2
18914.7
21731.1
31902.7
19206
14269.9
11023
14751.5
27063.9
27944.9
40175.3
42351.2
28999.7
19702.7
9065.1

Deferred Revenue Non Current

10607800-3.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

650---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

8940761064204285.4
5343.6
5198.8
5054.4
4577.3
4367.7
3974.1
3816.3
5440.1
5640.3
10923.7
4224.3
9451.6
4269.1
2949.7
3645.2

balance-sheet.row.total-non-current-liabilities

18890586083408940
16242.7
19760.2
22724.5
33242.2
20385.6
15621.6
11611.8
15450
28918.8
28431.5
40175.3
42351.2
29920.7
20623.8
9682.9

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

5680297033603420
3690.3
3065.2
0
0
0
0
0
0
0.6
32.2
42
66.1
99.5
60
0

balance-sheet.row.total-liab

80090402104041040150
51214.5
48396.8
49641.6
53030.3
38804.1
33373.6
29043.8
33184.8
47828.2
47621.6
48796.1
57103.5
38795.3
26432.1
13328.1

balance-sheet.row.preferred-stock

0000
0
0
0
0
2985.5
2985.5
2985.5
2985.5
7613.7
0
0
0
0
0
0

balance-sheet.row.common-stock

1440720720550
553.7
553.4
553.2
552.7
552.5
550.4
548.8
547.9
547.2
7999.3
7233
547.2
547.2
547.2
546.5

balance-sheet.row.retained-earnings

710071001276015290
11892.2
12634.9
14670.4
20555.4
23044.4
23929.4
0
0
5983.8
2684.3
1119.7
11069
12188.4
10115.7
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

9430871086801318.4
1281.5
1239.3
1203.6
1143.1
1965.5
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

46820170101633016601.6
12989.3
12320.4
12094.3
11115.9
9203.3
9417.5
32280.4
23508.4
565.5
-1252.6
0
0
0
0
7614.5

balance-sheet.row.total-stockholders-equity

64790335403849033760
26716.7
26748
28521.5
33367.1
37751.2
36882.8
35814.7
27041.8
14710.2
9431
8352.7
11616.1
12735.6
10662.9
8161

balance-sheet.row.total-liabilities-and-stockholders-equity

151030768308243077740
81789.1
78443.1
81620.4
90216.8
81208.6
71714.5
66220.2
60226.6
62538.4
57052.6
57148.8
68719.6
51530.9
37095
21489.1

balance-sheet.row.minority-interest

6150308035303830
3857.9
3298.3
3457.3
3819.4
4653.3
1458.1
1361.7
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

70940366204202037590
30574.6
30046.3
31978.8
37186.5
42404.5
38340.9
37176.4
27041.8
14710.2
9431
8352.7
11616.1
12735.6
10662.9
8161

balance-sheet.row.total-liabilities-and-total-equity

151030---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

10904704204.5
4.5
4.5
4.5
0.7
4.5
26.2
26.2
26.3
907.5
2852.8
948.3
931.9
709.4
3.1
3.1

balance-sheet.row.total-debt

44580218402198026740
35822.6
33746
37478.2
41588.1
26766
22522.2
19060.8
20704.7
34925
31845.5
40217.4
42417.3
29099.2
19762.8
9065.1

balance-sheet.row.net-debt

43140209401828024420
33629.2
29772.6
28505.8
31951.7
20136.2
10953.6
8060.6
10212.9
28038.8
27016.6
36747.6
35918.2
25297.4
10031
1925.8

现金流量表

在 Wockhardt Limited 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -1.279 的转变。该公司最近通过发行 -30 扩大了股本，与上一年相比出现了0.000 的差异. 有趣的是，公司的部分股票，特别是 0，是由公司自己回购的。这一举动导致0.000 比上一年有所变化。同时，以报告货币计算，公司的应付账款目前为 0. 公司的投资活动产生了现金使用净额，按报告货币计算达到-1250000000.000. 与上一年相比， -0.378 发生了变化. 在同一时期，公司记录了 2510, 50 和 -4060，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将0 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 940，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008200720062005

cash-flows.row.net-income

-5020-6240-41109160
-1966.8
-3003.2
-6411.5
-2471.5
2894.7
5753.4
8906.7
18602
5767.2
1043.5
-9856.4
-2509.6
4741.5
2941.7
2945.1

cash-flows.row.depreciation-and-amortization

2210251024702460
2257
1660.4
1495.3
1489.3
1419.1
1454
1399.2
1248.4
1225.1
1166.2
1491.5
1192.9
839.7
633.9
426.2

cash-flows.row.deferred-income-tax

0770-820-15210
-68.8
-105.6
-1082.5
-424.5
-469.3
-739.8
-796.9
-4132.1
5200.1
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0101020
22.6
15.8
66
109.7
72
169.2
202.3
258.2
102
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

015303670-1430
3795.8
802.9
2783.3
-2973.9
-3959.6
-3446.2
5879.9
-2669.9
-1299.4
449.9
-2442
-5696.7
-1976.5
-1695.6
-1074.2

cash-flows.row.account-receivables

01990703465.6
534.5
-2935.7
-698.1
350.1
-4871.2
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

01410300-1070
1295.3
363.5
2522.4
-41.9
-829.8
-278.9
-277.7
-2048.6
-1748.4
517.2
159.8
-610.1
-1114.2
-964.7
-583

cash-flows.row.account-payables

0009.1
-0.1
2937.2
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-18703300-3834.7
1966.1
437.9
959
-3282.1
1741.4
-3167.3
6157.6
-621.3
449
-67.3
-2601.8
-5086.6
-862.3
-730.9
-491.2

cash-flows.row.other-non-cash-items

-280295029102130
2449.8
2462.9
3833.8
1151.7
289.9
-380.8
-1625.2
-2114.7
7643.4
3758.5
8820.1
8258.5
167.4
5.3
-250.5

cash-flows.row.net-cash-provided-by-operating-activities

-3090000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-2090-2120-1660
-1723.9
-2748.7
-3074.1
-4106.2
-4919.4
-4405.1
-4625.1
-3414.3
-3175.4
-3004.2
-491.2
-6821.4
-3360.7
-2709.3
-1741.1

cash-flows.row.acquisitions-net

07901015350
89.4
53.7
13.5
18.7
858.5
0
0
12883.1
0
0
2433.7
0
-12985.4
-6552.1
0

cash-flows.row.purchases-of-investments

00-980-96
-1346.9
153.9
351.8
-5222.8
-7360.6
0
-5739.8
1104.4
0
0
1052
-17.7
-773
-350
0

cash-flows.row.sales-maturities-of-investments

0070356
4.3
2132.5
4476.6
21.7
3726.1
2472.1
0
687.8
0
0.2
0
0
100
350
0

cash-flows.row.other-investing-activites

0501010750
1421.8
1354.3
4534.6
2422.2
-486.5
-133.3
1848.7
697.1
120.9
237.9
5100.8
-5141.9
312.6
498.6
284.8

cash-flows.row.net-cash-used-for-investing-activites

0-1250-201014700
-1555.3
945.7
6302.4
-6866.4
-8181.9
-2066.3
-8516.2
10853.7
-3054.5
-2766.1
7043.3
-11980.9
-16706.6
-8762.8
-1456.3

cash-flows.row.debt-repayment

0-4060-20880-9550
-8818.8
-8192.1
-3094.7
-2026.9
-5035.5
-4663.3
-4588.5
-14426.7
-5236.6
-2850.6
-6896
-4065.9
-216.7
0
0

cash-flows.row.common-stock-issued

0-3074800.2
0.3
0.2
0.5
0.2
4.1
1.6
4.8
16.4
0
100.1
700
0
0
10.1
13.2

cash-flows.row.common-stock-repurchased

000-3540
0
-2713.6
0
0
6718.9
0
-578.7
-3508.7
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

00-20-10
0
-0.2
-1
-1381.8
-2
-2454.8
-1637.7
-4.7
-1.2
-1
-1.3
-321.3
-1738.1
-621.3
-614.9

cash-flows.row.other-financing-activites

0940127101389.8
2022.7
3141.2
-4599.5
15953.4
7576
6360
208.2
-9067.6
-3027.8
-978.4
2240.6
14786
8731.8
10149.8
-269.3

cash-flows.row.net-cash-used-provided-by-financing-activities

0-3150-710-11710
-6795.8
-7764.5
-7694.7
12544.9
2542.6
-756.5
-6013.2
-22457.5
-8265.6
-3729.9
-3956.7
10398.7
6777
9538.6
-871

cash-flows.row.effect-of-forex-changes-on-cash

070-3010
81.5
-13.5
43.9
22.8
-17.3
-156.4
282.9
-116.7
77.4
154.8
0
0
-53.4
-135.2
101.9

cash-flows.row.net-change-in-cash

-4030-28001380130
-1780
-4999
-664
3006.6
-4940.5
570.4
516.4
3603.5
2195.6
1560
1019.4
-1651
-5959.2
2592.4
-215.5

cash-flows.row.cash-at-end-of-period

238090037002320
2193.4
3973.4
8972.4
9636.4
6646.4
11586.9
11016.5
10500.1
6896.6
4701
3141
2121.6
3772.6
9731.8
7139.3

cash-flows.row.cash-at-beginning-of-period

6410370023202190
3973.4
8972.4
9636.4
6629.8
11586.9
11016.5
10500.1
6896.6
4701
3141
2121.6
3772.6
9731.8
7139.3
7354.8

cash-flows.row.operating-cash-flow

-309015304130-2870
6489.6
1833.2
684.4
-2694.7
716.1
3549.6
14762.9
15324
13438.3
6418.1
-1986.8
1245
3772.1
1885.4
2046.5

cash-flows.row.capital-expenditure

0-2090-2120-1660
-1723.9
-2748.7
-3074.1
-4106.2
-4919.4
-4405.1
-4625.1
-3414.3
-3175.4
-3004.2
-491.2
-6821.4
-3360.7
-2709.3
-1741.1

cash-flows.row.free-cash-flow

-3090-5602010-4530
4765.7
-915.5
-2389.7
-6800.9
-4203.3
-855.5
10137.8
11909.7
10262.9
3413.9
-2477.9
-5576.3
411.4
-823.9
305.4

利润表行

Wockhardt Limited 的收入与上期相比变化了 -0.176%。据报告, WOCKPHARMA.BO 的毛利润为 15350。该公司的营业费用为 16850，与上年相比变化了 -10.941%. 折旧和摊销费用为 2510，与上一会计期间相比变化了 0.016%. 营业费用报告为 16850，显示-10.941% 的同比变化。 销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。 基于近期数据的EBITDA为 0，同比增长-6.548%. 营业收入为 -1720，与上年相比变化了-6.548%. 净利润的变化率为 1.291%。去年的净收入为-5590.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008200720062005

income-statement-row.row.total-revenue

27710264603210026990
28330.3
35474
39077.3
40146.1
44532.2
44815.4
48303.6
56094.2
43505
37512.4
45014.2
35897.8
24908.2
17290.4
14130.4

income-statement-row.row.cost-of-revenue

11770111101267011350
12034.5
16363.1
17850.9
16620.7
16136.8
14874.8
18062.5
17475.6
15343.8
16414.6
19725.4
13603.5
9927.5
6678.5
5771.4

income-statement-row.row.gross-profit

15940153501943015640
16295.8
19110.9
21226.4
23525.4
28395.4
29940.6
30241.1
38618.6
28161.2
21097.8
25288.8
22294.2
14980.6
10611.9
8359

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

1260---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-180380301110
80.5
24.2
136.7
103.6
200.6
0
0
0
0
1366.6
-527.6
-1189.6
314.3
0
0

income-statement-row.row.operating-expenses

16580168501892018710
17518
20881.6
23276
24752.5
24720
23123.6
21842
18936.5
15560.2
12982.7
18243.6
15161.5
8915.3
7040.1
8079.9

income-statement-row.row.cost-and-expenses

28350279603159030060
29552.5
37244.7
41126.9
41373.2
40856.8
37998.4
39904.5
36412.1
30904
29397.3
37968.9
28765
18842.8
13718.6
13851.3

income-statement-row.row.interest-income

04060210
99.9
175.4
293.1
633.5
462.7
79.8
97.5
308.1
96.4
38.5
0
0
0
0
0

income-statement-row.row.interest-expense

2970291028202430
2696.4
2603.4
2473.5
2184.4
1184.3
537
828.5
1843
2671.8
2671
0
0
0
409.4
261.3

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-3480-4560-4480-2760.3
-2183.3
-2727.9
-4655
-1877.9
-1243.4
-255.4
-330.2
-1255.7
-7378.2
-7110.1
-16901.6
-9694.5
-1323.9
-630.1
-260

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-180380301110
80.5
24.2
136.7
103.6
200.6
0
0
0
0
1366.6
-527.6
-1189.6
314.3
0
0

income-statement-row.row.total-operating-expenses

-3480-4560-4480-2760.3
-2183.3
-2727.9
-4655
-1877.9
-1243.4
-255.4
-330.2
-1255.7
-7378.2
-7110.1
-16901.6
-9694.5
-1323.9
-630.1
-260

income-statement-row.row.interest-expense

2970291028202430
2696.4
2603.4
2473.5
2184.4
1184.3
537
828.5
1843
2671.8
2671
0
0
0
409.4
261.3

income-statement-row.row.depreciation-and-amortization

2210251024702460
2257
1660.4
1495.3
1489.3
1419.1
1454
1399.2
1248.4
1225.1
1166.2
1491.5
1192.9
839.7
633.9
426.2

income-statement-row.row.ebitda-caps

1950---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-850-1720310-3128.7
-1337
-1913
-2049.6
-1227.1
3675.4
6008.8
9236.9
19632.6
12590.1
8153.6
7045.3
7184.9
6065.3
3571.8
3205.1

income-statement-row.row.income-before-tax

-4330-6240-4110-5680
-3420.4
-4465.5
-6411.5
-2471.5
2894.7
5753.4
8906.7
18376.9
5211.9
1043.5
-9856.4
-2509.6
4741.5
2941.7
2945.1

income-statement-row.row.income-tax-expense

990-30-1320-2710
-2040.9
-1347.6
257
-211.1
378.8
1626.5
478.8
2582.1
2217.4
86.5
166.7
916.2
916.6
529.2
-374.1

income-statement-row.row.net-income

-8210-5590-24406860
-692.2
-1945.3
-6083
-1957.2
2507.2
4049.1
8407.1
15941.2
3415.9
905.2
-10006.6
-1388.6
3858.1
2412.5
3319.1
类似股票
您可能还对以下内容感兴趣：
CHSYF
China Medical System Holdings Limited.
0.9313 USD
PNK
600479.SS
ZhuZhou QianJin Pharmaceutical Co.,Ltd.
10.92 CNY
SHH
185750.KS
Chong Kun Dang Pharmaceutical Corp..
100300 KRW
KSC
ERIS.NS
Eris Lifesciences Limited.
848.1 INR
NSE
300601.SZ
Shenzhen Kangtai Biological Products Co., Ltd..
22.39 CNY
SHZ
TKPHF
Takeda Pharmaceutical Company Limited.
26.83 USD
PNK
MVP.AX
Medical Developments International Limited.
0.61 AUD
ASX
APLLTD.NS
Alembic Pharmaceuticals Limited.
1001.35 INR
NSE
128940.KS
Hanmi Pharm. Co., Ltd..
321500 KRW
KSC
002390.KS
HANDOK Inc..
13700 KRW
KSC

常见问题

什么是 Wockhardt Limited (WOCKPHARMA.BO) 总资产是多少？

Wockhardt Limited (WOCKPHARMA.BO) 总资产为 76830000000.000.

什么是企业年收入？

年收入为 14540000000.000.

企业利润率是多少？

公司利润率为 0.575.

什么是公司自由现金流？

自由现金流为 -21.443.

什么是企业净利润率？

净利润率为 -0.296.

企业总收入是多少？

总收入为 -0.031.

什么是 Wockhardt Limited (WOCKPHARMA.BO) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 -5590000000.000.

公司总债务是多少？

债务总额为 21840000000.000.

营业费用是多少？

运营支出为 16850000000.000.

公司现金是多少？

企业现金为 0.000.